Global and United States Cancer Biologics Market Report & Forecast 2023-2028

Report ID: 1871966 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cancer Biologics Revenue in Cancer Biologics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cancer Biologics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cancer Biologics Market Size for the Year 2017-2028
        1.2.2 Global Cancer Biologics Market Size for the Year 2017-2028
    1.3 Cancer Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cancer Biologics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cancer Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cancer Biologics Market Dynamics
        1.4.1 Cancer Biologics Industry Trends
        1.4.2 Cancer Biologics Market Drivers
        1.4.3 Cancer Biologics Market Challenges
        1.4.4 Cancer Biologics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cancer Biologics by Type
    2.1 Cancer Biologics Market Segment by Type
        2.1.1 Monoclonal Antibodies
        2.1.2 Vaccines
        2.1.3 Cell and Gene Therapy
        2.1.4 Others
    2.2 Global Cancer Biologics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cancer Biologics Market Size by Type (2017-2028)
    2.4 United States Cancer Biologics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cancer Biologics Market Size by Type (2017-2028)
3 Cancer Biologics by Application
    3.1 Cancer Biologics Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Cancer Biologics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cancer Biologics Market Size by Application (2017-2028)
    3.4 United States Cancer Biologics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cancer Biologics Market Size by Application (2017-2028)
4 Global Cancer Biologics Competitor Landscape by Company
    4.1 Global Cancer Biologics Market Size by Company
        4.1.1 Top Global Cancer Biologics Companies Ranked by Revenue (2021)
        4.1.2 Global Cancer Biologics Revenue by Player (2017-2022)
    4.2 Global Cancer Biologics Concentration Ratio (CR)
        4.2.1 Cancer Biologics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biologics in 2021
        4.2.3 Global Cancer Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cancer Biologics Headquarters, Revenue in Cancer Biologics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cancer Biologics Headquarters and Area Served
        4.3.2 Global Cancer Biologics Companies Revenue in Cancer Biologics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cancer Biologics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cancer Biologics Market Size by Company
        4.5.1 Top Cancer Biologics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cancer Biologics Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Biologics Market Size by Region
    5.1 Global Cancer Biologics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cancer Biologics Market Size by Region (2017-2028)
        5.2.1 Global Cancer Biologics Market Size by Region: 2017-2022
        5.2.2 Global Cancer Biologics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cancer Biologics Market Size YoY Growth 2017-2028
        6.1.2 North America Cancer Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cancer Biologics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cancer Biologics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cancer Biologics Market Size YoY Growth 2017-2028
        6.3.2 Europe Cancer Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cancer Biologics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cancer Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cancer Biologics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cancer Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Company Details
        7.1.2 Roche Business Overview
        7.1.3 Roche Cancer Biologics Introduction
        7.1.4 Roche Revenue in Cancer Biologics Business (2017-2022)
        7.1.5 Roche Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Cancer Biologics Introduction
        7.2.4 Novartis Revenue in Cancer Biologics Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Company Details
        7.3.2 Eli Lilly Business Overview
        7.3.3 Eli Lilly Cancer Biologics Introduction
        7.3.4 Eli Lilly Revenue in Cancer Biologics Business (2017-2022)
        7.3.5 Eli Lilly Recent Development
    7.4 Sanofi
        7.4.1 Sanofi Company Details
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Cancer Biologics Introduction
        7.4.4 Sanofi Revenue in Cancer Biologics Business (2017-2022)
        7.4.5 Sanofi Recent Development
    7.5 Celgene
        7.5.1 Celgene Company Details
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Cancer Biologics Introduction
        7.5.4 Celgene Revenue in Cancer Biologics Business (2017-2022)
        7.5.5 Celgene Recent Development
    7.6 Pfizer
        7.6.1 Pfizer Company Details
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Cancer Biologics Introduction
        7.6.4 Pfizer Revenue in Cancer Biologics Business (2017-2022)
        7.6.5 Pfizer Recent Development
    7.7 Bayer
        7.7.1 Bayer Company Details
        7.7.2 Bayer Business Overview
        7.7.3 Bayer Cancer Biologics Introduction
        7.7.4 Bayer Revenue in Cancer Biologics Business (2017-2022)
        7.7.5 Bayer Recent Development
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Company Details
        7.8.2 Johnson & Johnson Business Overview
        7.8.3 Johnson & Johnson Cancer Biologics Introduction
        7.8.4 Johnson & Johnson Revenue in Cancer Biologics Business (2017-2022)
        7.8.5 Johnson & Johnson Recent Development
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Company Details
        7.9.2 Bristol-Myers Squibb Business Overview
        7.9.3 Bristol-Myers Squibb Cancer Biologics Introduction
        7.9.4 Bristol-Myers Squibb Revenue in Cancer Biologics Business (2017-2022)
        7.9.5 Bristol-Myers Squibb Recent Development
    7.10 Merck
        7.10.1 Merck Company Details
        7.10.2 Merck Business Overview
        7.10.3 Merck Cancer Biologics Introduction
        7.10.4 Merck Revenue in Cancer Biologics Business (2017-2022)
        7.10.5 Merck Recent Development
    7.11 Amgen
        7.11.1 Amgen Company Details
        7.11.2 Amgen Business Overview
        7.11.3 Amgen Cancer Biologics Introduction
        7.11.4 Amgen Revenue in Cancer Biologics Business (2017-2022)
        7.11.5 Amgen Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Biologics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Biologics Market Trends
    Table 3. Cancer Biologics Market Drivers
    Table 4. Cancer Biologics Market Challenges
    Table 5. Cancer Biologics Market Restraints
    Table 6. Global Cancer Biologics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Biologics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Biologics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Biologics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Biologics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Biologics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Biologics Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Biologics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biologics as of 2021)
    Table 15. Top Players of Cancer Biologics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Biologics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Biologics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Biologics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Biologics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Biologics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Biologics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Biologics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Biologics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Biologics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Cancer Biologics Product
    Table 33. Roche Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Cancer Biologics Product
    Table 38. Novartis Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Eli Lilly Company Details
    Table 41. Eli Lilly Business Overview
    Table 42. Eli Lilly Cancer Biologics Product
    Table 43. Eli Lilly Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 44. Eli Lilly Recent Development
    Table 45. Sanofi Company Details
    Table 46. Sanofi Business Overview
    Table 47. Sanofi Cancer Biologics Product
    Table 48. Sanofi Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 49. Sanofi Recent Development
    Table 50. Celgene Company Details
    Table 51. Celgene Business Overview
    Table 52. Celgene Cancer Biologics Product
    Table 53. Celgene Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 54. Celgene Recent Development
    Table 55. Pfizer Company Details
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Cancer Biologics Product
    Table 58. Pfizer Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. Bayer Company Details
    Table 61. Bayer Business Overview
    Table 62. Bayer Cancer Biologics Product
    Table 63. Bayer Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 64. Bayer Recent Development
    Table 65. Johnson & Johnson Company Details
    Table 66. Johnson & Johnson Business Overview
    Table 67. Johnson & Johnson Cancer Biologics Product
    Table 68. Johnson & Johnson Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 69. Johnson & Johnson Recent Development
    Table 70. Bristol-Myers Squibb Company Details
    Table 71. Bristol-Myers Squibb Business Overview
    Table 72. Bristol-Myers Squibb Cancer Biologics Product
    Table 73. Bristol-Myers Squibb Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 74. Bristol-Myers Squibb Recent Development
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Cancer Biologics Product
    Table 78. Merck Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Amgen Company Details
    Table 81. Amgen Business Overview
    Table 82. Amgen Cancer Biologics Product
    Table 83. Amgen Revenue in Cancer Biologics Business (2017-2022) & (US$ Million)
    Table 84. Amgen Recent Development
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Biologics Product Picture
    Figure 2. Global Cancer Biologics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Biologics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Biologics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Biologics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Biologics Market Share in Global 2017-2028
    Figure 7. Cancer Biologics Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Vaccines
    Figure 10. Product Picture of Cell and Gene Therapy
    Figure 11. Product Picture of Others
    Figure 12. Global Cancer Biologics Market Share by Type in 2022 & 2028
    Figure 13. Global Cancer Biologics Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Cancer Biologics Market Share by Type (2017-2028)
    Figure 15. United States Cancer Biologics Market Share by Type in 2022 & 2028
    Figure 16. United States Cancer Biologics Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Cancer Biologics Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Cancer Biologics Market Share by Application in 2022 & 2028
    Figure 22. Global Cancer Biologics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Cancer Biologics Market Share by Application (2017-2028)
    Figure 24. United States Cancer Biologics Market Share by Application in 2022 & 2028
    Figure 25. United States Cancer Biologics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Cancer Biologics Market Share by Application (2017-2028)
    Figure 27. North America Cancer Biologics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Cancer Biologics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Cancer Biologics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Cancer Biologics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Cancer Biologics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Cancer Biologics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Roche Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 57. Eli Lilly Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 59. Celgene Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 61. Bayer Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 64. Merck Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 65. Amgen Revenue Growth Rate in Cancer Biologics Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Eli Lilly
Sanofi
Celgene
Pfizer
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Merck
Amgen
Frequently Asked Questions
Cancer Biologics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Biologics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Biologics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports